A new cancer drug called trastuzumab deruxtecan, also known as Enhertu, has just been approved in the UK. This drug is designed to help adults with certain types of advanced cancer that cannot be removed by surgery, or which has spread to other parts of the body.
It targets cancers linked to a protein called HER2. This approval is an exciting development because it could save lives and offer hope to patients who may have run out of treatment options.
